Sign in to continue:

Monday, March 2nd, 2026

Disclosure of Share Dealings in ENN Natural Gas Co., Ltd. by China International Capital Corporation Limited – Hong Kong Takeovers Code Compliance 1




Disclosure of Dealings in ENN Natural Gas Co., Ltd. Shares

Public Disclosure: Dealings in ENN Natural Gas Co., Ltd. Shares Amid Privatisation Scheme

Key Points for Investors

  • Date of Disclosure: 2 March 2026
  • Transaction Date: 27 February 2026
  • Relevant Party: China International Capital Corporation Limited (CICC)
  • Nature of Dealings: Creation of new index-tracking ETFs involving ENN Natural Gas Co., Ltd. shares
  • Transaction Details:
    • Type of Securities: Ordinary shares (A shares)
    • Transaction Type: Purchase
    • Total Number of Shares Involved: 2,200
    • Total Amount Paid: RMB 44,825.00
    • Highest Price Paid: RMB 20.40 per share
    • Lowest Price Paid: RMB 20.35 per share
  • Context: The dealings relate to the creation of new ETFs. The relevant ENN Natural Gas shares represent less than 1% of the total class in issue and less than 20% of the value of the securities in the basket or index.
  • Connection: China International Capital Corporation Limited is an exempt principal trader connected with the Offeror, and the dealings were made for its own account.
  • Currency: Transactions were conducted in RMB.

Important Information for Shareholders

Shareholders should note that this disclosure comes in the context of the planned privatisation of ENN Natural Gas Co., Ltd. by way of a scheme of arrangement. The reported transaction involves the purchase of a relatively small number of shares (2,200) by CICC for the creation of new index-tracking ETFs. While the volume is minor compared to the total shares outstanding, the activity is noteworthy because it signals ongoing trading and institutional interest during a sensitive period related to privatisation.

Price Sensitivity: The prices paid (RMB 20.35–20.40 per share) can provide a reference for recent trading levels. Although the transaction itself may not be substantial enough to move the share price significantly, it is important for shareholders to monitor such disclosures. Activity by connected parties—especially exempt principal traders—can sometimes foreshadow larger moves or signal confidence (or uncertainty) around the privatisation process.

Potential Impact: The creation of ETFs that include ENN Natural Gas shares, even in small quantities, can increase demand and liquidity for the stock, albeit modestly. The connection between the trader (CICC) and the Offeror may also be relevant for those tracking the progress and dynamics of the privatisation scheme.

Investor Takeaways

  • Monitor ongoing disclosures and trading activity by connected parties during the privatisation process.
  • Take note of recent transaction prices as indicative of market sentiment.
  • Consider the implications of ETF creation for liquidity, even if the immediate impact is limited.

Disclaimer

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research and consult with professional advisors before making investment decisions. The information is based on public disclosures and may be subject to change.




View ENN ENERGY Historical chart here



Jiumaojiu Acquires 49% Equity in Big Way Hot Pot for USD43 Million: Discloseable Transaction Announcement

Jiumaojiu International Announces Major Equity Acquisition in North American Hot Pot Chain Jiumaojiu International Announces Major Equity Acquisition in North American Hot Pot Chain “Big Way Hot Pot” Key Highlights Major Investment Announced: Jiumaojiu...

Ruisen Life Service Co, Limited Quarterly Update on Resumption Progress and Trading Status (Feb 2026)

Ruisen Life Service Co, Limited – Detailed Quarterly Update on Resumption Progress and Key Developments Ruisen Life Service Co, Limited: In-Depth Quarterly Update on Resumption Progress, Financial Restoration, and Key Management Changes Key Takeaways...

Duality Biotherapeutics Presents Promising Phase 1/2 Results for DB-1311/BNT324 in Metastatic Castration-Resistant Prostate Cancer at ASCO GU 2026 12

Duality Biotherapeutics Presents Positive Study Results for DB-1311/BNT324 at ASCO GU Symposium 2026 Duality Biotherapeutics Presents Positive Study Results for DB-1311/BNT324 at ASCO GU Symposium 2026 Key Highlights Updated efficacy and safety results from...

   Ad